Echo Therapeutics, creator of a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system called Symphony and a transdermal drug delivery system called Prelude SkinPrep, recently debuted a demonstration video on its company website, reports MedGadget. The new video showcases the use of the Symphony system in a home setting and coincides with an upcoming clinical study.
The...
